Summary
[Buchang Pharmaceutical: Subsidiary’s drug plans to win the bid for the fifth batch of national drug centralized procurement]Buchang Pharmaceutical (603858) announced on the evening of June 24 that its wholly-owned subsidiary Buchang Gaoxin participated in the National Organization for Drug Centralized Procurement and Use of Joint Procurement Office Organized the fifth batch of tenders for the national centralized drug procurement. Buchang high-tech drug metoprolol tartrate tablets plans to win the bid for this centralized procurement. If Buchang Hi-tech subsequently signs and implements the purchase contract, it will help the company to further expand the sales of related products, increase market share, enhance the company’s brand influence, and have a positive impact on the company’s future operating results. (E company)
Buchang Pharmaceutical(603858) Evening of June 24announcement, A wholly-owned subsidiary, Buchang Gaoxin, participated in the fifth batch of national centralized drug procurement bids organized by the National Organization for Drug Centralized Purchase and Use of the Joint Procurement Office. Buchang high-tech drug metoprolol tartrate tablets plans to win the bid for this centralized procurement.If Buchang Hi-tech signs subsequent purchasescontractAfter the implementation, it will help the company to further expand the sales of related products, increase market share, enhance the company’s brand influence, and affect the company’s future operations.PerformanceHas a positive impact.
(Article source: e company)
.